A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis

Study Identifier
198782-005
CT.gov Identifier
NCT00518089
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Study Details

Medical Condition
  • Conjunctivitis
    • Study Drug
  • Gatifloxacin 0.5% eye drops
  • placebo eye drops
    • Phase
    Phase 3
    Sex
    Female & Male
    Age
    1+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    * Clinically diagnosed with bacterial conjunctivitis
    Exclusion Criteria:
    * Signs and/or symptoms of conjunctivitis for more than 96 hours * Signs and/or symptoms suggestive of fungal, viral, or allergic conjunctivitis * Clinical diagnosis of chlamydia in either eye

    Protocol Summary

    The study will determine the safety and efficacy of gatifloxacin eye drops in patients with bacterial conjunctivitis

    Study Locations

    Location
    Status
    Location
    Downey, California, United States
    Status
    Not applicable
    Location
    RajajiNagar, Bangalore, India
    Status
    Not applicable